Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma.
about
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice.Renin-angiotensin inhibitors reprogram tumor immune microenvironment: A comprehensive view of the influences on anti-tumor immunity
P2860
Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Use of inhibitors of the renin ...... with hepatocellular carcinoma.
@en
Use of inhibitors of the renin ...... with hepatocellular carcinoma.
@nl
type
label
Use of inhibitors of the renin ...... with hepatocellular carcinoma.
@en
Use of inhibitors of the renin ...... with hepatocellular carcinoma.
@nl
prefLabel
Use of inhibitors of the renin ...... with hepatocellular carcinoma.
@en
Use of inhibitors of the renin ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1476
Use of inhibitors of the renin ...... with hepatocellular carcinoma.
@en
P2093
Arndt Weinmann
Dan G Duda
Florian Hucke
Jens U Marquardt
Marcus-Alexander Wörns
Matthias Pinter
Michael Trauner
Peter R Galle
Rakesh K Jain
Simona Bota
P2860
P304
P356
10.1177/2050640617695698
P577
2017-02-26T00:00:00Z